In 2001, the US Food and Drug Administration approved recombinant tissue plasminogen activator (alteplase, Cathflo Activase) to reestablish patency of central catheters occluded, presumably, by a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback